5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Behavioural Pharmacology

• Publication date

  2016-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/FBP.0000000000000183PMID 26292187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Can 5-HT3 antagonists contribute toward the treatment of schizophrenia?

  2015influential reference
• Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

  2015cited by this paper
• Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics.

  2015cited by this paper
• Maternal lipopolysaccharide treatment differentially affects 5-HT(2A) and mGlu2/3 receptor function in the adult male and female rat offspring.

  2015cited by this paper
• Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice.

  2014cited by this paper
• 5-HT(2A) and mGlu2 receptor binding levels are related to differences in impulsive behavior in the Roman Low- (RLA) and High- (RHA) avoidance rat strains.

  2014cited by this paper
• Neurotrophins and psychiatric disorders.

  2014cited by this paper
• Neuroendocrine changes upon exposure to predator odors.

  2014cited by this paper
• Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.

  2013cited by this paper
• Prenatal Stress Induces Schizophrenia-Like Alterations of Serotonin 2A and Metabotropic Glutamate 2 Receptors in the Adult Offspring: Role of Maternal Immune System

  2013cited by this paper
• The two faces of the pharmacological interaction of mGlu2 and 5-HT₂A - relevance of receptor heterocomplexes and interaction through functional brain pathways.

  2013cited by this paper
• Repressive Epigenetic Changes at the mGlu2 Promoter in Frontal Cortex of 5-HT2A Knockout Mice

  2013cited by this paper
• A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia

  2013cited by this paper
• Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.

  2013influential reference
• Anxiety-like behaviour and associated neurochemical and endocrinological alterations in male pups exposed to prenatal stress.

  2012cited by this paper
• Pharmacological Activation of Group-II Metabotropic Glutamate Receptors Corrects a Schizophrenia-Like Phenotype Induced by Prenatal Stress in Mice

  2012influential reference
• Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades.

  2012cited by this paper
• Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications

  2012cited by this paper
• Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia.

  2012cited by this paper
• DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation.

  2012cited by this paper
• HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

  2012cited by this paper
• Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.

  2011cited by this paper
• Impulsive behaviour in rats induced by intracortical DOI infusions is antagonized by co-administration of an mGlu2/3 receptor agonist

  2011cited by this paper
• Maternal Influenza Viral Infection Causes Schizophrenia-Like Alterations of 5-HT2A and mGlu2 Receptors in the Adult Offspring

  2011cited by this paper
• Metabotropic glutamate receptors: from the workbench to the bedside.

  2011cited by this paper
• Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

  2011cited by this paper
• Schizophrenia: treatment targets beyond monoamine systems.

  2011cited by this paper
• Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice

  2011cited by this paper
• Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression

  2011cited by this paper
• Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.

  2010cited by this paper
• Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.

  2010cited by this paper
• Enhanced Function of Prefrontal Serotonin 5-HT2 Receptors in a Rat Model of Psychiatric Vulnerability

  2010cited by this paper
• Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia.

  2010influential reference
• The serotonin 5-HT2A receptor agonist TCB-2: a behavioral and neurophysiological analysis

  2010cited by this paper
• Metabotropic glutamate receptors: physiology, pharmacology, and disease.

  2010cited by this paper
• Effects of acute systemic administration of serotonin2A/C receptor ligands in a delay-based decision-making task in rats

  2009cited by this paper
• Psychedelics and schizophrenia.

  2009cited by this paper
• Activation of mGlu2/3 Metabotropic Glutamate Receptors Negatively Regulates the Stimulation of Inositol Phospholipid Hydrolysis Mediated by 5-Hydroxytryptamine2A Serotonin Receptors in the Frontal Cortex of Living Mice

  2009cited by this paper
• Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants

  2009cited by this paper
• The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs.

  2008influential reference
• Identification of a serotonin/glutamate receptor complex implicated in psychosis

  2008influential reference
• The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity

  2008cited by this paper
• Sensorimotor gating of schizophrenia patients is influenced by 5-HT2A receptor polymorphisms.

  2008cited by this paper
• The neuropharmacology of impulsive behaviour.

  2008cited by this paper
• Metabotropic Glutamate Receptor 2 and 3 Gene Expression in The Human Prefrontal Cortex and Mesencephalon in Schizophrenia

  2008cited by this paper
• Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection

  2008cited by this paper
• Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex

  2007cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.

  2007cited by this paper
• Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear.

  2007cited by this paper
• Habituation Deficits Induced by Metabotropic Glutamate Receptors 2/3 Receptor Blockade in Mice: Reversal by Antipsychotic Drugs

  2007cited by this paper
• Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control

  2007cited by this paper
• A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis

  2007influential reference
• Behavioral disinhibition requires dopamine receptor activation

  2006cited by this paper
• 5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740.

  2006cited by this paper
• Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU2/3 receptor agonist LY379268

  2005cited by this paper
• The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity

  2005cited by this paper
• Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

  2005cited by this paper
• Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat.

  2005cited by this paper
• BDNF in schizophrenia, depression and corresponding animal models

  2005cited by this paper
• Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.

  2004cited by this paper
• Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia

  2004cited by this paper
• A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases

  2003cited by this paper
• Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders

  2003cited by this paper
• Divergent Stress Responses and Coping Styles in Psychogenetically Selected Roman High-(RHA) and Low-(RLA) Avoidance Rats: Behavioural, Neuroendocrine and Developmental Aspects

  2003cited by this paper
• Glutamate metabotropic receptors as targets for drug therapy in epilepsy.

  2003cited by this paper
• In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents.

  2003cited by this paper
• Group II Metabotropic Glutamate Receptor Modulation of DOI-induced c-fos mRNA and Excitatory Responses in the Cerebral Cortex

  2003cited by this paper
• Alpha-adrenoceptor-mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task.

  2003cited by this paper
• Serotonin 5-Hydroxytryptamine2A Receptor-Coupled Phospholipase C and Phospholipase A2 Signaling Pathways Have Different Receptor Reserves

  2003cited by this paper
• Serotonin receptors: their key role in drugs to treat schizophrenia.

  2003cited by this paper
• The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats.

  2003cited by this paper
• α‐Adrenoceptor‐Mediated Modulation of 5‐HT2 Receptor Agonist Induced Impulsive Responding in a 5‐Choice Serial Reaction Time Task

  2003cited by this paper
• The metabotropic glutamate receptors: structure, activation mechanism and pharmacology.

  2002cited by this paper
• Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors.

  2002cited by this paper
• Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice.

  2002influential reference
• Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

  2001cited by this paper
• Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task.

  2001cited by this paper
• A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex.

  2001cited by this paper
• Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists.

  2001cited by this paper
• Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites.

  2001cited by this paper
• DOI-Induced Activation of the Cortex: Dependence on 5-HT2A Heteroceptors on Thalamocortical Glutamatergic Neurons

  2000cited by this paper
• Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors

  2000influential reference
• Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus.

  2000cited by this paper
• Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain.

  2000cited by this paper
• Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.

  2000influential reference
• Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors

  2000influential reference
• A review of central 5-HT receptors and their function.

  1999influential reference
• Activation of immediate early genes and memory formation

  1999cited by this paper
• c-Fos proteins, induced by the serotonin receptor agonist DOI, are not expressed in 5-HT2A positive cortical neurons.

  1999cited by this paper
• Inbred Roman high- and low-avoidance rats: differences in anxiety, novelty-seeking, and shuttlebox behaviors.

  1999cited by this paper
• Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release.

  1999influential reference
• Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain.

  1999cited by this paper
• LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.

  1998cited by this paper
• Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.

  1997cited by this paper
• Serotonin 5‐HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex

  1997cited by this paper
• 5-HT2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex

  1997cited by this paper
• DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum.

  1997cited by this paper
• Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells.

  1997influential reference
• Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.

  1997cited by this paper

• mGlu2 Receptors in the Basal Ganglia: A New Frontier in Addiction Therapy

  2025cites this paper
• Serotonin (5‐Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities

  2025cites this paper
• Serotonin 2A (5-HT2A) receptor as evolving biological target: function, structure, ligands and role in the therapy of neuropsychiatric diseases.

  2025cites this paper
• Genetic Inactivation of the Serotonin Transporter Dysregulates Expression of Neurotransmission Genes and Genome‐Wide DNA Methylation Levels in the Medial Prefrontal Cortex of Male Rats During Postnatal Development

  2025influential citation
• Adaptive Changes in Group 2 Metabotropic Glutamate Receptors Underlie the Deficit in Recognition Memory Induced by Methamphetamine in Mice

  2024cites this paper
• Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.

  2023cites this paper
• Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.

  2023cites this paper
• Metamodulation of presynaptic NMDA receptors: New perspectives for pharmacological interventions.

  2023cites this paper
• The role of metabotropic glutamate receptors in neurobehavioral effects associated with methamphetamine use.

  2023cites this paper
• Modulation of DOM-Induced Head-Twitch Response by mGluR2 Agonist/Inverse Agonist is Associated with 5-HT2AR-Mediated Gs Signaling Pathway

  2023cites this paper
• Influence of developmental nicotine exposure on serotonergic control of breathing‐related motor output

  2022cites this paper
• Presynaptic 5-HT2A-mGlu2/3 Receptor–Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis

  2022cites this paper
• 5-HT 2A -mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: a 5-HT 2A to mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis

  2022cites this paper
• Genetic variants of the type-3 metabotropic glutamate receptor gene associated with human spatial localization ability

  2021cites this paper
• Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence

  2021cites this paper
• Antidepressants and Psychological Treatment: Hard Reasons for Synergy

  2021cites this paper
• Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors

  2021cites this paper
• Serotonergic metamodulation of mGlu2 3 receptors, a new mechanism for pain management: the case of trazodone

  2021cites this paper
• Neuro- und Psychopharmakologie

  2020cites this paper
• Molecular, biochemical and behavioural evidence for a novel oxytocin receptor and serotonin 2C receptor heterocomplex.

  2020cites this paper
• Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT2A/mGlu2 Receptor Complex.

  2020cites this paper
• Attenuation of Oxytocin and Serotonin 2A Receptor Signaling through Novel Heteroreceptor Formation.

  2019cites this paper
• Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update

  2019cites this paper
• Biomarker Opportunities to Enrich Clinical Trial Populations for Drug Development in Schizophrenia and Depression

  2019cites this paper
• Novel Approaches to the Development of Antimigraine Drugs: A Focus on 5-HT2A Receptor Antagonists

  2019cites this paper
• 5‐HT2A‐mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5‐HT2A to mGlu2/3 signalling to amplify presynaptic mechanism of auto‐control of glutamate exocytosis

  2018cites this paper
• Chronic methamphetamine self‐administration dysregulates 5‐HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK‐801

  2018influential citation
• Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice

  2018cites this paper
• Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia

  2016cites this paper
• The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia

  2016cites this paper
• Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders.

  2016cites this paper